Fig. 8From: Role of the indoleamine-2,3-dioxygenase/kynurenine pathway of tryptophan metabolism in behavioral alterations in a hepatic encephalopathy rat modelEffects of the IDO inhibitor 1-MT (9 mg/kg) on IDO1 expression in the hippocampus (a1) and cerebral cortex (b1) in different days (0, 7, 14, 21, and 28 days) after BDL surgery. Analytical results of a1 are summarized in a2, and detailed results of b1 are summarized in b2. Data are expressed as mean ± SEM (n = 6). *p < 0.05, **p < 0.01, and ***p < 0.001, when compared to the sham group; ##p < 0.01 and ###p < 0.001, when compared to the BDL groupBack to article page